30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

1H16 M&A Recap: Big Players Make Moves

During 1H16, seven of the eight largest orthopaedic device companies confirmed or completed acquisitions or divestitures spanning nearly every orthopaedic market segment. Here we present a full list of M&A transactions from the first half of the year.

1H16 Funding Recap: Spine Remains Dominant Market for Investments

ORTHOWORLD reported 18 funding announcements in 1H16, compared to 23 in 1H15. Similar to recent years, the spine market was the largest target for funding.

Investors Talk Technology, People and Funding Fundamentals

Investors continue to tout healthcare IT as a strong space for funding, yet most of the backing in orthopaedics is focusing on traditional technologies.

Medtronic's Analyst Day Highlights Spine, Joint Recon Strategies

In its Analyst Day presentations, Medtronic announced the acquisition of Responsive Orthopedics, a start-up focused on sales of low-cost hip and knee replacements. A primary knee is slated for commercial U.S. availability within 1H17; a primary hip is expected to follow in 1H18.

Trauma Surgeon Reflects on Experiences with R&D, FDA and Zimmer Biomet Partnership

ORTHOKNOW interviewed the surgeon inventor of N-force’ to understand his take on the trauma market and the future of implant delivery.

Page Navigation